The reporter learned from the State Drug Administration that the National Drug Supervision and Administration Work Conference held from January 6 to 7 clarified the four key tasks of drug supervision in 2026: one is to make every effort to ensure a high level of drug safety; the second is to actively support the development of the pharmaceutical industry to improve quality and efficiency; the third is to continuously raise the level of legalization of drug supervision; and fourth, to steadily modernize drug supervision.

The reporter learned from the State Drug Administration that the National Drug Supervision and Administration Work Conference held from January 6 to 7 clarified the four key tasks of drug supervision in 2026: one is to make every effort to ensure a high level of drug safety; the second is to actively support the development of the pharmaceutical industry to improve quality and efficiency; the third is to continuously raise the level of legalization of drug supervision; and fourth, to steadily modernize drug supervision.